Swiss Research Excellence Restored: ERC Grants Return After Three-Year Gap

Swiss science is back on the European map. For the first time in over three years, the prestigious European Research Council (ERC) has awarded Advanced Grants to researchers in Switzerland, ending a painful period of isolation. In a resounding comeback, 20 Swiss researchers have secured these coveted awards, signaling a critical reintegration into the continent's elite scientific community. This breakthrough comes after a stark three-year hiatus that began in spring 2021, when negotiations on a framework agreement with the EU collapsed, leaving Swiss innovation out in the cold.

The numbers tell a story of resilience. Out of 281 total projects funded across the continent, Switzerland has claimed a significant share, proving that despite political headwinds, the nation's research quality remains undiminished. This is not merely a bureaucratic update; it is a restoration of status. The ERC Advanced Grants are among the most competitive and prestigious in the world, targeting established research leaders. By securing these spots, Switzerland is emphatically reclaiming its seat at the table of European innovation, ending a drought that threatened to erode the country's competitive edge in global science.

The Federal Institutes of Technology have asserted their dominance with crushing authority. Of the 20 grants awarded to Switzerland, a staggering 12 have gone to the federal powerhouses. The Swiss Federal Institute of Technology Lausanne (EPFL) leads the charge with seven grants, while ETH Zurich follows closely with five. This concentration of excellence highlights the pivotal role these institutions play in maintaining Switzerland’s scientific reputation on the global stage.

However, the success is not limited to the federal giants. The University of Basel secured three grants, demonstrating robust research capabilities. Meanwhile, the Universities of Bern, Geneva, and Zurich, along with the Paul Scherrer Institute (PSI) and the Idiap research institute, each claimed one grant. This distribution underscores a breadth of talent across the Swiss landscape, but the message is clear: when it comes to European competition, EPFL and ETH Zurich are the heavyweights carrying the national flag. Their ability to secure funding in such a competitive environment—where only established leaders succeed—reaffirms their status as premier hubs for cutting-edge discovery.

This scientific victory is the direct result of a fragile but critical diplomatic thaw. Since May 2021, Swiss researchers were effectively locked out of these grants, classified as coming from a "non-associated third country" after the Swiss government walked away from framework agreement negotiations. The relationship was rocky, and the cost was paid in lost opportunities and severed networks. The turnaround began only recently, with the resumption of negotiations between Bern and the EU Commission in March 2024.

Under a new "transitional arrangement," Switzerland is once again being treated as an "associated third country" for the purpose of these specific grants. This political maneuver has reopened the pipeline, allowing Swiss talent to compete on merit rather than be disqualified by geography. While the broader political relationship remains complex, this specific agreement acts as a vital lifeline. It proves that science can sometimes precede politics, forcing doors open that diplomacy had previously slammed shut. The reintegration is a pragmatic acknowledgement that excluding a research powerhouse like Switzerland hurts European science as a whole.

The financial implications of this return are massive, but there is a catch: the EU isn't writing the checks—Switzerland is. While the prestige comes from the European Research Council, the actual cash is flowing from Bern. In April 2024, the Swiss government mobilized a massive CHF 600 million ($740 million) to fund the participation of its researchers. This "pay-to-play" model ensures that while the accolades are European, the burden remains on the Swiss taxpayer for now.

The stakes for individual researchers are incredibly high. Each ERC Advanced Grant offers up to €2.5 million (approx. CHF 2.35 million) per project. This level of funding is transformative, allowing established scientists to pursue high-risk, high-reward inquiries that standard grants simply cannot support. By fronting the money, the Swiss government is making a calculated bet: that the long-term value of keeping Swiss science integrated with Europe far outweighs the immediate fiscal cost. As negotiations continue, the hope is for a full return to normalcy, but for now, Switzerland is buying its way back in—and the results suggest it is money well spent.